Corresponding Authors’ information:
1. Salamanca University Hospital, Paseo de San Vicente, 58-182, 37007
Salamanca
2. University of Salamanca, Paseo de San Vicente, 58-182, 37007
Salamanca
3. Instituto de Investigación Biomédica de Salamanca (IBSAL) Paseo de
San Vicente, 58-182, 37007 Salamanca
4. Galvanize Therapeutics, Inc. 1531 Industrial Rd. San Carlos, CA 94070
Disclosure Statement: William Krimsky, MD is employed by
Galvanize Therapeutics, Inc. Marcelo Jimenez and Jose Fernandez have not
identified a conflict of interest.
ClinicalTrials.gov Identifier: NCT04732520
Funding Statement: Funding for the INCITE ES trial is provided
to the Salamanca University Hospital by Galvanize Therapeutics, Inc.
EC Number and Date of Approval: C.E.I.M. reference 20/1615
(E.C.P.S.), approved January 22, 2021.
Informed Consent Statement: The patient was identified as an
appropriate candidate and consented for study, standard of care
procedures, and publication of the data for the Ethics
Committee-approved INCITE ES trial (NCT04732520).
Corresponding Author Contact Information: William Krimsky,
Galvanize Therapeutics, 1531 Industrial Rd, San Carlos, CA 94070
Article Word Count:750
Key Clinical Message: Hybrid ORs rarely support multiple
specialties at once. We present a case where several specialties
collaborated, mitigating non-diagnostic procedures when therapy relied
on intraprocedural diagnosis.
Keywords: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung,
Thoracic Surgical Procedures, Operating Rooms.
Glossary of Abbreviations: OR (operating room), NSCLC
(non-small cell lung cancer), CT (computed tomography), RUL (right upper
lobe), PET (positron emission tomography), SUV (standardized uptake
value), PEF (pulsed electric field), CBCT (cone-beam computed
tomography), PACU (post anesthesia care unit).